AUM and trading activity drives Oppenheimer's wealth management business. Read why we remain bullish on OPY stock.
YAVNE, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics ...
Alphabet (GOOGL) will be stepping up to the earnings plate tomorrow (February 4), when it will deliver its fourth quarter ...
Hosted on MSN20h
Oppenheimer’s Worst Fear…Over the years, we’ve heard hundreds of time about how we have enough nuclear weapons to destroy the world. But is that ...
About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...
After the music industry gave out its prestigious Grammys Sunday, the film community is gearing up for its ceremony to take ...
Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...
This year’s Doomsday Clock Statement landed like a damp squib in a Trump-swamped corporate news cycle on January 28th. The ...
Patient Capital Management stated the following regarding Coinbase Global, Inc. (NASDAQ:COIN) in its Q4 2024 investor letter: ...
Albemarle (NYSE:ALB – Get Free Report) was downgraded by research analysts at Evercore ISI from an “outperform” rating to an ...
8d
cryptopolitan on MSNOppenheimer downgrades Apple, cites weakening iPhone sales and AI innovation worriesOppenheimer downgraded Apple from "outperform" to "perform" because it is struggling to adapt to a competitive AI landscape.
Oppenheimer (NYSE:OPY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Monday. Oppenheimer Trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results